Single dose of antibiotic leaves mice highly vulnerable to intestinal infection

January 20, 2012

Yet another study adds to the growing evidence that antibiotics can disrupt the balance of the intestinal flora, with negative effects on health. A team of researchers from the Memorial Sloan Kettering Cancer Center, New York City, has shown in mouse models that a single dose of the commonly used antibiotic, clindamycin, wiped out nearly 90 percent of bacterial taxa, leaving the mice unusually susceptible to infection by Clostridium difficile, a bacterial pathogen that is innocuous for most health people but that can cause severe diarrhea in individuals following antibiotic treatment.  Their research appears in the January issue of the journal Infection and Immunity.

Clindamycin was already known to be “highly associated with the development of Clostridium difficile infections” in humans and mice, says corresponding author Eric G. Pamer. In earlier work, Trevor Lawley had shown that clindamycin administration results in chronic shedding of C. difficile spores by infected mice. The researchers, who included Pamer’s colleagues Charlie Buffie and Joao Xavier, hypothesized that “clindamycin-mediated destruction of the complex but stable networks of interacting and interdependent bacterial species [in the intestine] would result in marked instability of the microbiota,” that would leave the mice vulnerable to infection, says Pamer, adding that “Our long-term goal is to determine which intestinal bacteria provide resistance to difficile infection.”

Following the single dose of clindamycin, the investigators “found that mice became highly susceptible to infection and developed severe weight loss, and had a mortality rate of roughly 40 percent,” says Pamer. “Surviving mice continued to be infected with C. difficile for 28 days and had persistent bowel inflammation.”

Next the team investigated clindamycin’s impact on the intestinal microbioata, by isolating the contents of the small intestine and the cecum, and using the “454 deep DNA sequencing platform” to identify species. “To our surprise, roughly 87 percent of the bacterial species that were present prior to were undetectable following clindamycin administration, a loss of diversity that persisted for the 28 day duration of this study,” says Pamer. During this time, the bacterial species composition fluctuated wildly.

The study demonstrates how the application of deep sequencing platforms to analyze complex microbial populations, such as those that inhabit the human gut can lead to understanding, and perhaps predicting susceptibility to infection by highly antibiotic resistant bacteria, such as C. difficile or vancomycin resistant Enterococcus, says Pamer.

The research was largely supported by the Tow Foundation, which provided a grant to support the Lucille Castori Center for Microbes, Inflammation, and Cancer at Memorial Sloan-Kettering Cancer Center.

Explore further: Probiotics appear to mitigate pancreatitis: Surprising hypothetical mechanism warrants further investigation

More information: C.G. Buffie, et al., 2011. Profound alterations of intestinal microbiota following a single dose of clindamycin results in sustained susceptibility to Clostridium difficile-induced colitis. Infect. Immun. 80:62-73.

Related Stories

Probiotics appear to mitigate pancreatitis: Surprising hypothetical mechanism warrants further investigation

November 17, 2011
(Medical Xpress) -- A probiotic treatment appears to mitigate pancreatitis in an animal model, leading to a new hypothesis of how probiotics may act, according to a paper in the November Applied and Environmental Microbiology. ...

Compound in Apples Inhibits E. coli O157:H7

December 16, 2011
A compound that is abundant in apples and strawberries inhibits the highly pathogenic E. coli O157:H7 biofilms while sparing a beneficial strain of E. coli that also forms biofilms in the human gut, according to a paper in ...

Research identifies new way to treat common hospital-acquired infection

August 21, 2011
Researchers at the David Geffen School of Medicine at UCLA and the University of Texas Medical Branch at Galveston have discovered a molecular process by which the body can defend against the effects of Clostridium difficile ...

Recommended for you

Co-infection with two common gut pathogens worsens malnutrition in mice

July 27, 2017
Two gut pathogens commonly found in malnourished children combine to worsen malnutrition and impair growth in laboratory mice, according to new research published in PLOS Pathogens.

Finish your antibiotics course? Maybe not, experts say

July 27, 2017
British disease experts on Thursday suggested doing away with the "incorrect" advice to always finish a course of antibiotics, saying the approach was fuelling the spread of drug resistance.

Phase 3 trial confirms superiority of tocilizumab to steroids for giant cell arteritis

July 26, 2017
A phase 3 clinical trial has confirmed that regular treatment with tocilizumab, an inhibitor of interleukin-6, successfully reduced both symptoms of and the need for high-dose steroid treatment for giant cell arteritis, the ...

A large-scale 'germ trap' solution for hospitals

July 26, 2017
When an infectious airborne illness strikes, some hospitals use negative pressure rooms to isolate and treat patients. These rooms use ventilation controls to keep germ-filled air contained rather than letting it circulate ...

Researchers report new system to study chronic hepatitis B

July 25, 2017
Scientists from Princeton University's Department of Molecular Biology have successfully tested a cell-culture system that will allow researchers to perform laboratory-based studies of long-term hepatitis B virus (HBV) infections. ...

Male hepatitis B patients suffer worse liver ailments, regardless of lifestyle

July 25, 2017
Why men with hepatitis B remain more than twice as likely to develop severe liver disease than women remains a mystery, even after a study led by a recent Drexel University graduate took lifestyle choices and environments ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.